Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Economist: Waller's Position May Be Slightly More Accommodative than Powell's

Economist: Waller's Position May Be Slightly More Accommodative than Powell's

CointimeCointime2026/04/27 23:19

On April 28, as the obstacles to Kevin Waller being confirmed as the next Federal Reserve Chairman seem to be diminishing, the market is reassessing what this change might bring. AMP Chief Economist Shane Oliver stated that Waller is committed to maintaining the independence of the Federal Reserve and may place greater emphasis on AI transformation rather than on employment. Oliver noted that he might also focus more on trimmed mean inflation rather than core PCE, although this could be seen as selective. Oliver added that his stance may be slightly more accommodative than Powell's, but there will not be any fundamental differences.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

On Monday, storage chip concept stocks generally rose, with SanDisk (SNDK.US) up by 6%.

智通财经2026/08/17 13:51
U.S. Stocks Movement | Storage Chip Concept Stocks Rise Across the Board, SNDK (SanDisk) Up 6%

AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds

On August 17, AstraZeneca (AZN.US) and Daiichi Sankyo jointly announced that the Phase III DESTINY-Lung04 study of Enhertu (trastuzumab deruxtecan) as a monotherapy for first-line treatment of non-small cell lung cancer (NSCLC) has achieved highly positive results.

智通财经2026/08/17 12:56
AstraZeneca (AZN.US) / Daiichi Sankyo ADC first-line lung cancer phase III study succeeds